Bexarotene in Treating Patients With Metastatic Breast Cancer

NCT00003752 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: bexarotene

Sponsor

Ligand Pharmaceuticals